AGMB SCHEDULE 13G/A: SEC filing

Redmile Group, LLC and affiliated reporting persons

Filed with the SEC on · accession 0000905148-26-004929

AGMB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -6.1% by the first close after the filing.

Summary of the filing

Redmile Group, LLC and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of 1,740,230 American Depositary Shares of AgomAb Therapeutics NV, representing approximately 3.5% of the company's common shares outstanding.

Key details

American Depositary Shares beneficially owned$1.7M
Percentage of common shares outstanding$4
Reporting person / investment managerRedmile Group, LLC
Direct holder of the adssRedmile Biopharma Investments III, L.P.
IssuerAgomAb Therapeutics NV
Managing member of redmile group, llc and principal of redmileJeremy C. Green

How AGMB stock reacted

Close before

$6.36

Nov 13, 2026

First close after

-6.13%

$5.97

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for AGMB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AGMB?

Click here

Frequently asked questions

What did AGMB file with the SEC on Nov 16, 2026?

AGMB filed a SCHEDULE 13G/A (SEC filing). Redmile Group, LLC and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of 1,740,230 American Depositary Shares of AgomAb Therapeutics NV, representing approximately 3.5% of the company's common shares outstanding.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did AGMB stock react to this filing?

AGMB closed at $6.36 before the filing and $5.97 on Nov 16, 2026 (-6.13%).

Other AGMB SEC filings

Get alerts when AGMB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days